Two Sigma Investments
BIAF icon

Two Sigma Investments’s bioAffinity Technologies BIAF Stock Holding History

Two Sigma Investments’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-721
Closed -$31.8K – 3040
2023
Q4 		$31.8K Hold
721
– – ﹤0.01% 3033
2023
Q3 		$25.2K Sell
721
-7
-1% -$355 ﹤0.01% 2862
2023
Q2 		$40K Sell
728
-158
-18% -$8.72K ﹤0.01% 2848
2023
Q1 		$50.2K Buy
+886
New +$51.3K ﹤0.01% 2753

Other funds holding BIAF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Two Sigma Investments's BIAF Position: Q1 2024 in Review

Two Sigma Investments sold out of bioAffinity Technologies (BIAF) in Q1 2024, closing a stake of 721 shares — an estimated $31.8K sold.

Two Sigma Investments first reported a position in BIAF in Q1 2023 and held it in 4 quarters. The position peaked at $50.2K in Q1 2023. 13 funds tracked by Wall St. Rank hold BIAF as of Q1 2024.

  • Two Sigma Investments reported no remaining bioAffinity Technologies position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Investments sold 721 bioAffinity Technologies shares in Q1 2024, an estimated $31.8K.
  • Two Sigma Investments first reported a position in bioAffinity Technologies in Q1 2023 and held it in 4 quarters.
  • Two Sigma Investments's bioAffinity Technologies position peaked at $50.2K in Q1 2023.
  • 13 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.